Early Treatment with Sotrovimab for Covid-19
N Engl J Med
.
2022 Apr 14;386(15):1480-1481.
doi: 10.1056/NEJMc2201606.
Epub 2022 Mar 16.
Author
Yasuhiro Fujiwara
1
Affiliation
1
Pharmaceuticals and Medical Devices Agency, Tokyo, Japan fujiwara-ce@pmda.go.jp.
PMID:
35294998
DOI:
10.1056/NEJMc2201606
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal, Humanized / therapeutic use
Antibodies, Neutralizing
COVID-19 Drug Treatment*
Humans
Substances
Antibodies, Monoclonal, Humanized
Antibodies, Neutralizing
sotrovimab